Kane Biotech Inc Ord (KNBIF) Q3 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kane Biotech Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:01.750 Good afternoon and thank you for standing by. 00:00:01.750 -- 00:00:06.674 Welcome to Kean Biotech's third quarter 2024 earnings conference call. 00:00:06.674 -- 00:00:10.277 During today's presentation, all parties will be in a listen-only mode. 00:00:10.277 -- 00:00:13.879 Following the presentation, the conference call will be open to questions. 00:00:13.879 -- 00:00:18.102 If you have a question, please press star then 11 on your touchtone phone. 00:00:18.102 -- 00:00:21.945 If you would like to withdraw your question, please press star 11 again. 00:00:21.945 -- 00:00:24.287 This conference is being recorded today, December 3rd, 2024. 00:00:24.287 -- 00:00:28.942 I would now like to turn the conference call over to Ray Dupuy. 00:00:28.942 -- 00:00:33.383 Kane Biotech's Chief Financial Officer, please go ahead. 00:00:33.743 -- 00:00:38.534 Thank you, operator. Good afternoon and welcome everyone to Kane Biotech's third quarter 00:00:38.534 -- 00:00:40.024 2024 00:00:40.024 -- 00:00:44.565 earnings conference call. We are delighted to have you join us today. 00:00:44.565 -- 00:00:49.046 This call will cover Kane's financial and operating results along with the discussion 00:00:49.046 -- 00:00:54.647 of some of our recent highlights and goals for the remainder of 2024 and beyond. 00:00:54.647 -- 00:00:59.161 Following our prepared remarks, we will open the conference call to a question and answer 00:00:59.161 -- 00:01:04.182 session. Our call today will be led by CAEN's Chief Executive Officer, 00:01:04.182 -- 00:01:06.182 Mark Edwards. 00:01:06.182 -- 00:01:10.103 Before we begin our formal remarks, I would like to remind everyone that some of the 00:01:10.103 -- 00:01:15.824 statements on this conference call contain certain for...